ENTITY

Oryzon Genomics (ORY SM)

Analysis

Health Care • Spain

Oryzon Genomics, SA is a clinical stage biopharmaceutical company that develops epigenetics-based therapeutics.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"